https://www.einpresswire.com/article/829424800/2025-crf-international-conference-unites-global-chm-community-for-research-education-and-connection Nearly 200 attendees from around the world gathered to advance research and support for those affected by choroideremia (CHM). SPRINGFIELD, MA, UNITED STATES, July 9, 2025 /EINPresswire.com/
https://www.einpresswire.com/article/819471616/choroideremia-research-foundation-announces-six-new-global-grants-to-accelerate-vision-science CRF awards six global grants to advance CHM research, spanning AI, gene editing, and more—driving progress toward treatments for this rare retinal disease. SPRINGFIELD, MA, UNITED STATES,
Proposals related to finding a cure for a rare inherited retinal disease are due by June 30, 2025. SPRINGFIELD, MA, UNITED STATES, April 21, 2025 /EINPresswire.com/ — The
READ MORE: https://www.einpresswire.com/article/791418042/choroideremia-research-foundation-announces-2025-international-conference-advancing-chm-research-treatment-and-support SPRINGFIELD, MA, UNITED STATES, March 6, 2025 /EINPresswire.com/ — The Choroideremia Research Foundation (CRF) is excited to announce the 2025 CRF International Conference, taking place
CHOROIDEREMIA RESEARCH FOUNDATION ACCELERATES SCIENTIFIC RESEARCH OF RARE INHERITED RETINAL DISEASE WITH THREE GRANTS https://www.einpresswire.com/article/743897348/choroideremia-research-foundation-accelerates-scientific-research-of-rare-inherited-retinal-disease-with-three-grants The foundation names it’s 4th annual Randy Wheelock Award winner SPRINGFIELD, MA, UNITED
CHOROIDEREMIA RESEARCH FOUNDATION EXPANDS LEADERSHIP AND STRENGTHENS COMMITMENT TO RARE RETINAL DISEASE RESEARCH News Provided by EIN Presswire | Jul 16, 2024, 7:16 PM ET CRF has funded
SPRINGFIELD, MA, UNITED STATES, April 16, 2024 /EINPresswire.com/ — The Choroideremia Research Foundation (CRF) is pleased to announce its latest scientific research grants, supporting its mission to find
Encinitas, California–(Newsfile Corp. – April 11, 2024) – Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has received grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments
On April 4, 2024, CRF signed a letter of support for Emixustat hydrochloride, a drug with potential for maintaining retinal health, to treat Stargart’s disease. Read the CRF
Dr. Jasleen Jolly receives the Ricketts Family Research Award to Investigate Rare Inherited Retinal Disorders SPRINGFIELD, MA. – March 3, 2021 – The Choroideremia Research Foundation (CRF)
